Millbrae, CA, February 4, 2026 (Globe Newswire) -- Eikon Therapeutics set the price for an upsized initial public offering of 21,177,600 common shares at $18.00 each and granted underwriters a 30-day option to buy up to 3,176,640 additional shares. The company expects gross proceeds of roughly $381 million before fees and expenses (excluding any proceeds from the option), with trading anticipated to begin on Feb. 5, 2026, subject to customary closing conditions. Read full a

Chelmsford, M A, February 4, 2026 (ZOLL) -- ZOLL Medical (an Asahi Kasei company) appointed Eric Knudsen as Chief Executive Officer, effective April 1, 2026. Knudsen will succeed Jon Rennert, who led ZOLL for the past 10 years and will move into the role of Executive Chairman of the Board. ZOLL highlighted Knudsen’s nearly 30 years in medtech, including leading corporate development at ZOLL and most recently serving as President of ZOLL Itamar, where he oversaw significant

Indianapolis and Watertown, MA, February 9, 2026 (PRNewswire) -- Eli Lilly signed a definitive agreement to acquire Orna Therapeutics, adding a circular RNA + lipid nanoparticle platform designed to engineer immune cells inside the body rather than via traditional ex vivo manufacturing. Read full article here .

San Francisco, CA, January 22, 2026 (Business Wire) -- Mendra launched with an oversubscribed $82 million Series A financing to acquire, develop, and commercialize therapies for rare diseases with high unmet need. The round was co-led by OrbiMed, 8VC, and 5AM Ventures, with participation from Lux Capital and Wing VC. The company plans to leverage artificial intelligence to accelerate patient identification, clinical trial enrollment, and global commercialization as it build

Kingston, NY, January 27, 2026 (PRNewswire) -- Millrock Technology has appointed Tom Hochuli as Chief Executive Officer, bringing more than 30 years of leadership across life sciences, medical devices, and biologics manufacturing. Hochuli joins at a pivotal growth stage and is expected to strengthen Millrock’s position as a trusted innovator in advanced freeze-drying and processing technologies for pharma and biotech customers. His background includes leading operational tr

Minneapolis & Brisbane, January 22, 2026 (Globe Newswire) -- Anteris Technologies Global Corp. announced a $90 million strategic investment from Medtronic, bringing total gross proceeds to $320 million when combined with a concurrent underwritten equity offering. The funding will support execution of Anteris’ global pivotal PARADIGM trial and accelerate progress toward worldwide commercialization of its DurAVR® transcatheter heart valve for aortic stenosis. Company leaders

Princeton, NJ, January 28, 2026 (Business Wire) -- Taiho Oncology appointed Peter Melnyk as President and Chief Executive Officer, effective immediately, following the retirement of Tim Whitten after 13 years of leadership. Melnyk brings more than three decades of experience in oncology commercialization across pharma, biotech, and medical devices, most recently serving as Chief Commercial Officer at Alpha Tau Medical. His appointment comes as Taiho Oncology builds on recen

Berkeley Heights, NJ, January 22, 2026 (Globe Newswire) -- Corxel Pharmaceuticals closed a Series D1 financing of up to $287 million to accelerate development of its cardiometabolic portfolio, led by the oral small-molecule GLP-1 receptor agonist CX11. The proceeds will fund ongoing U.S. Phase 2 studies in obesity and overweight patients, planned global Phase 2 trials in type 2 diabetes, early Phase 3 preparations, and additional programs spanning acute ischemic stroke and

Menlo Park, CA, January 12, 2026 (Business Wire) -- Inquis Medical closed a $75 million Series C financing from an undisclosed strategic investor to accelerate nationwide commercial expansion of its AVENTUS thrombectomy system and advance its next-generation pipeline. The raise follows a pivotal year in which the company transitioned to a commercial-stage organization, expanded regulatory clearance for pulmonary embolism, and published positive pivotal trial data demonstrat

Billerica, MA, January 8, 2026 (Business Wire) -- Quanterix Corporation appointed Everett Cunningham as President and Chief Executive Officer, effective January 19, 2026, as part of a planned leadership transition. Cunningham joins from Illumina, where he served as Chief Commercial Officer, following earlier commercial leadership roles at Exact Sciences, Quest Diagnostics, GE Healthcare, and Pfizer. The company said it expects to exceed its full-year 2025 revenue and cash g

Boston, MA, January 9, 2026 (PRNewswire) -- Haemonetics Corporation announced the acquisition of Vivasure Medical Limited, a Galway-based medtech company developing next-generation percutaneous vessel closure technology. Vivasure’s PerQseal® Elite system uses a fully bioabsorbable, suture-free patch to close large-bore access sites and has already secured CE Mark approval in Europe, with a U.S. FDA PMA submission completed in 2025. The deal includes €100 million in upfront

Melville, NY, January 12, 2026 (Business Wire) -- Henry Schein, Inc. announced the appointment of Frederick M. Lowery as Chief Executive Officer, effective March 2, 2026, at which point he will also join the Board of Directors. Lowery succeeds Stanley M. Bergman, who will step down after 35 years as CEO and continue as Chairman to support a smooth leadership transition. Lowery brings more than 20 years of healthcare distribution and operational leadership experience, most r